Endotracheal Tube Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Regular Endotracheal Tube, Reinforced Endotracheal Tube, Preformed Endotracheal Tube), By Route (Orotracheal, Nasotracheal), By Application, By End Use, By Region, And Segment Forecasts

Endotracheal Tube Market Summary

The global endotracheal tube market size was estimated at USD 2.15 billion in 2025 and is projected to reach USD 3.60 billion by 2033, growing at a CAGR of 6.80% from 2026 to 2033. The market is primarily driven by the rising incidence of respiratory diseases, the increasing number of surgical procedures requiring general anesthesia, and the growing demand for critical care services.

Technological advancements such as improved tube materials, antimicrobial coatings, and enhanced patient safety features further support market growth.

In addition, expanding healthcare infrastructure and greater adoption of emergency medical services contribute to increased usage worldwide. According to the Global Initiative of Chronic Obstructive Lung Disease, the global prevalence of COPD is 10.3%. According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) and asthma are the most common chronic respiratory diseases (CRDs), with COPD accounting for nearly 80% of CRD-related deaths. With an aging global population and multiple health challenges, COPD cases are projected to rise by 23% worldwide by 2050, disproportionately affecting women and individuals in low- and middle-income countries.

The rising prevalence of respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and acute respiratory distress syndrome (ARDS), is a key driver of the market. As more patients experience severe respiratory conditions, the demand for reliable airway management during critical care, emergency interventions, and surgical procedures increases. Hospitals and healthcare providers are increasingly relying on endotracheal tubes to ensure effective ventilation and prevent complications, thereby fueling global market growth.

In respiratory diseases, COPD is a major factor driving the endotracheal tube industry. Patients with COPD frequently require airway management and mechanical ventilation during exacerbations, surgeries, or critical care interventions. The growing number of COPD cases increases demand for reliable, effective endotracheal tubes to maintain proper ventilation and prevent complications. Consequently, the rising prevalence of COPD significantly contributes to the expansion of the market.According to the Australian Institute of Health and Welfare, in 2023, COPD accounted for 3.6% of the total disease burden and represented 50% of the total burden from respiratory conditions. Similarly, according to the CDC, in 2023, the age-adjusted prevalence of diagnosed chronic obstructive pulmonary disease (COPD) among adults aged 18 and older was 3.8%, with a higher prevalence in women (4.1%) compared to men (3.4%).

As a result, the increasing prevalence of respiratory diseases, particularly COPD, is expected to drive higher use of endotracheal tubes, as more patients require airway management and mechanical ventilation. This growing demand for reliable intubation devices is expected to drive significant expansion of the market.

Furthermore, the growth in global surgical procedures is boosting demand for endotracheal tubes. As the number of surgeries rises, especially in cardiac, thoracic, and emergency procedures, there is an increased need for reliable airway management to ensure patient safety and effective ventilation. Endotracheal tubes are essential for maintaining airways during anesthesia, making them a critical requirement in operating rooms. This surge in surgical volumes directly drives higher adoption and growth of the market worldwide.

For instance, the surgeries performed in Canada between April 1 and June 30, 2025, saw a significant volume across hospitals and surgical centers. The table below reflects the ongoing demand for operative procedures and associated medical equipment, including endotracheal tubes. 

Surgeries performed in Canada (April 1 - June 30, 2025)

Source: Saskatchewan

Number of surgical operations and procedures in EU (2022)

Source: Eurostat

Similarly, the rising prevalence of cancer in men and women is one of the driving factor of the Endotracheal Tube (ETT) industry, as patients often require airway management during surgery, critical care, or palliative treatment. Surgeries for thoracic, abdominal, and head and neck cancers, along with complications from chemotherapy or radiation, increase the need for intubation. Advanced-stage cancer patients and immunocompromised individuals frequently require mechanical ventilation, further boosting demand for endotracheal tubes.

As a result, the rising prevalence of respiratory diseases, increasing number of surgical procedures, and growing cancer cases are collectively driving higher demand for endotracheal tubes, as these conditions frequently require airway management and mechanical ventilation to ensure patient safety and effective treatment outcomes.

Market Concentration & Characteristics

The endotracheal tube industry is experiencing a high degree of innovation, with advancements such as antimicrobial coatings, improved cuff designs, and integrated sensors enhancing patient safety and ventilation efficiency. Smart and reinforced tubes, along with designs tailored for specific surgical and critical care needs, are driving adoption. Continuous research and development are enabling more reliable, comfortable, and clinically effective airway management solutions. For instance, in May 2025, NCBI published an article on the Sleeve-Type Endotracheal Tube (STET), a modular device designed to improve one-lung ventilation, reduce airway trauma, and enhance safety. Its dual-cuff system ensures stable positioning and accommodates diverse patient populations. Early pilot testing has shown promising structural stability, flexibility, and clinical potential in thoracic surgery and critical care.

The endotracheal tube industry has witnessed a moderate level of mergers and acquisitions, as leading medical device companies aim to expand their product portfolios and strengthen their global presence. Strategic acquisitions help companies gain access to advanced technologies, specialized tube designs, and emerging regional markets. This trend is supporting market consolidation while driving innovation and competitive growth. For instance, in May 2025, Sterimed announced the inclusion of IK Partners and several new investors in a management-led consortium alongside its existing shareholders. The consortium features long-term investor Sagard, which increased its stake, as well as new members Société Générale CP, Geneo CE, Capza, and Investir pour l’Enfance, collectively called “Friends of Sterimed.” Longstanding family and entrepreneurial investors also remain shareholders by joining the group. Financial terms of the transaction were not disclosed.

Regulations play a significant role in the endotracheal tube industry, ensuring that products meet strict safety, quality, and performance standards. Compliance with FDA, CE, and other regional guidelines affects product approvals, manufacturing processes, and market entry timelines. While regulatory oversight enhances patient safety and trust, it can also increase development costs and extend time-to-market for new innovations.

End use concentration in the endotracheal tube industry is primarily centered in hospitals and critical care settings, which account for most of the demand due to high surgical volumes and emergency interventions. Clinics and specialty care centers emerge as growing end-users, driven by outpatient procedures and minor surgeries. This concentration reflects the reliance on advanced healthcare infrastructure and trained medical personnel for effective airway management.

Product Insights

The regular endotracheal tube segment dominated the market in 2025, Due to its wide applicability, cost-effectiveness, and high usage in surgical and critical care procedures, these tubes are the standard choice in most healthcare settings for providing mechanical ventilation and ensuring airway patency during surgeries, trauma care, and emergencies. The simplicity of design, ease of use, and availability of various sizes make regular ETTs suitable for adult and pediatric patients. In addition, the lower cost of regular tubes compared to advanced variants such as antimicrobial-coated or subglottic suction ETTs makes them highly preferred in low- and middle-income countries where budget constraints are prevalent. Technological advancements, the lack of widespread awareness, and the higher cost of innovative ETTs further contribute to the dominance of regular ETTs in the market.

The reinforced endotracheal tube segment is expected to exhibit the fastest CAGR during the forecast period. Reinforced endotracheal tubes are used during neurosurgeries and facial surgeries. According to the WHO, over 1 in 3 people are affected by neurological conditions, the leading cause of illness and disability worldwide. The requirement for neurosurgical procedures is anticipated to fuel the market. Reinforced ETTs are widely used in neurosurgery, maxillofacial, and ENT surgeries, where maintaining a secure airway is critical. New products are expected to support segment growth in the forecast years. 

Route Insights

The orotracheal segment dominated the market in 2025 and also expected to be the fastest growing market in the forecast period, due to its high reliability and ease of insertion making it the preferred choice for clinicians in surgical, emergency, and critical care settings. The widespread adoption of this method ensures consistent airway management, supporting its strong market presence. Growing surgical volumes and focus on patient safety further supports its dominance.

Nasotracheal tubes are significantly growing in the market due to their increasing use in complex surgeries, dental procedures, and long-term ventilation cases. Its advantages in patient comfort and secure airway management are driving wider adoption among clinicians. Rising awareness of specialized airway techniques and advancements in tube design are further supporting the growth of this segment.

Application Insights

The emergency treatment segment dominated the market in 2025 and is also expected to grow fastest over the forecast period. Due to the critical need for rapid and reliable airway management in trauma, cardiac arrest, and other urgent medical situations. The high demand in emergency and pre-hospital care settings ensures widespread adoption of endotracheal tubes. Their effectiveness in maintaining ventilation and preventing airway obstruction makes them the preferred choice for clinicians in urgent care scenarios.

The therapy segment is significantly growing in the market as demand for long-term ventilation and respiratory support rises in critical care and chronic illness management. Advancements in tube design, such as improved cuff technology and antimicrobial features, are enhancing patient safety and comfort. Increasing awareness of effective respiratory therapies and expanding ICU infrastructure are further driving this segment's growth.

End Use Insights

Hospitals dominate the market due to the high volume of surgical procedures, critical care treatments, and emergency interventions conducted in these settings. Their need for reliable airway management solutions to ensure patient safety drives widespread adoption of endotracheal tubes. Well-established procurement systems trained medical staff, and advanced ICU and operating room infrastructure further position hospitals as the leading end users in the market.

Clinics are the fastest-growing segment during the forecast period, driven by the increasing number of outpatient surgeries, minor procedures, and emergency care services provided in these settings. Rising awareness of advanced airway management techniques and growing investments in clinic infrastructure are supporting the adoption of endotracheal tubes. Their convenience, efficiency, and focus on patient safety make clinics an emerging and rapidly expanding end-user segment.

Regional Insights 

The endotracheal tube industry in North America held the largest share and accounted for 37.45% of global revenue in 2025. driven by a strong focus on patient safety, infection prevention, and improved clinical outcomes. Hospitals are adopting advanced tube designs with better cuff control, biocompatible materials, and features that reduce ventilation-associated complications. There is also a growing emphasis on standardization of airway management protocols across emergency, surgical, and intensive care settings. In addition, continuous training of healthcare professionals supports the uptake of newer, performance-oriented products.

U.S. Endotracheal Tube Market Trends

The U.S. endotracheal tube industry is experiencing significant growth as there is a clear shift toward advanced, safety-focused products, including tubes with improved sealing cuffs and materials that minimize airway trauma and infection risk. The increased use of video-assisted intubation and its integration with digital monitoring tools are influencing purchasing decisions in hospitals and emergency settings. Ongoing initiatives to enhance airway management training among clinicians are also driving the adoption of innovative tube designs. With high volumes of surgical procedures and critical care beds, demand remains strong and continues to grow significantly.

Europe Endotracheal Tube Market Trends

The endotracheal tube industry in Europe is driven by an increased focus on reducing ventilator-associated complications and enhancing patient comfort, leading to wider adoption of ergonomically designed, antimicrobial-coated tubes. Regional emphasis on clinical guidelines and standardized airway management practices is encouraging the use of high-quality, evidence-based devices in both surgical and ICU settings. Cross-border collaborations and investments in healthcare infrastructure are also supporting the uptake of innovative airway management solutions across key European countries

The UK endotracheal tube industry is showing significant growth, supported by increased healthcare spending and a strong focus on improving airway management outcomes. Hospitals are progressively adopting advanced tubes with better safety features to reduce complications and enhance patient comfort. Demand is also rising due to ongoing elective surgeries and investment in critical care infrastructure. In addition, clinical training initiatives are reinforcing the use of newer, more effective intubation devices across healthcare settings.

The France endotracheal tube industry is experiencing significant growth, fueled by hospitals and clinics prioritize investments in advanced airway management solutions to improve patient safety and reduce respiratory complications. There is increasing uptake of tubes with enhanced cuff technology and biocompatible materials, driven by strong clinical focus on quality care in surgical and ICU settings. Ongoing healthcare infrastructure upgrades and emphasis on standardized clinical protocols are also supporting market growth. In addition, professional training for anesthesiologists and critical care teams is bolstering the adoption of innovative products. According to the World Population Review, a total of 415,800 surgical procedures were performed in France in 2024.

Asia Pacific Endotracheal Tube Market Trends

The Asia Pacific endotracheal tube industry is experiencing growth, driven by expanding healthcare infrastructure, rising surgical volumes, and greater access to critical care services across emerging economies. There is increasing adoption of advanced tubes with improved safety features as hospitals focus on reducing complications and enhancing patient outcomes. Markets in China, India, and Southeast Asia are particularly dynamic, supported by rising healthcare expenditure and growing clinical awareness. In addition, continuous training of healthcare professionals is helping to increase demand for higher-quality airway management products.

The endotracheal tube industry in China is growing rapidly, driven by expanding healthcare infrastructure and heightened focus on patient safety. Rising numbers of surgeries and critical care procedures are boosting demand for tubes with improved cuff designs and infection‑prevention features. Investments in modern hospital facilities and enhanced clinician training are further supporting market adoption, while the emphasis on international standards is driving the use of high-quality airway management devices.

Latin America Endotracheal Tube Market Trends

The endotracheal tube industry in Latin America is growing significantly as hospitals and clinics modernize airway management equipment to enhance patient care. Increasing surgical volumes and expanding critical care services, particularly in Brazil and Mexico, are driving demand. Adoption of safer, higher-quality tubes is rising, though cost considerations remain influential. The improved clinician training and standardized clinical protocols are supporting broader market uptake.

MEA Endotracheal Tube Market Trends

The endotracheal tube industry in the MEA is gradually expanding as hospitals enhance critical care and surgical capabilities, particularly in countries like Saudi Arabia, the UAE, and South Africa. Growth is driven by rising cases of respiratory illnesses and increased demand for safe, advanced intubation devices. While cost sensitivity and uneven healthcare development in some areas limit rapid expansion, ongoing investments in infrastructure and clinician training are supporting market adoption. 

Key Endotracheal Tube Company Insights

The global endotracheal tube industry is dominated by established players offering a wide range of standard and advanced tubes, including antimicrobial-coated and specialized designs. These leading manufacturers hold a significant share of the market, while smaller and regional companies compete by offering cost-effective, niche solutions, helping expand adoption across hospitals, surgical centers, and critical care units worldwide.

Recent Developments

• In January 2026, airway management remains a major focus in modern anesthesia and emergency medicine. With rising surgical volumes, aging populations, and increasing emphasis on patient safety, the demand for reliable, standardized, and clinically validated airway devices is growing. The laryngeal mask airway has become a key technology, transforming how clinicians manage ventilation in both routine and complex procedures.

• In March 2025, the U.S. FDA recalled certain oral and nasal endotracheal tubes from Smiths Medical after finding that some sizes may have a smaller diameter than expected. The reduced diameter can result in insufficient ventilation, posing serious health risks including hypoxia, laryngeal edema, cardiopulmonary arrest, organ failure, and death.

• In July 2024, Medtronic recalled NIM Contact EMG Reinforced Endotracheal Tubes and NIM (Standard) EMG Reinforced Endotracheal Tubes due to reports of tube blockages caused by cuff herniation, in some cases resulting from overinflation of the endotracheal tube cuff.

• In February 2024, Medline Industries, LP, recalled six SubG Endotracheal Tubes with Subglottic Suction and ten kits after reports that components could detach or tear, causing loss of inflation and airway compromise. These defects may lead to serious risks, including respiratory distress, re-intubation, airway obstruction, hypoxemia, organ damage, and cardiorespiratory arrest.

• In November 2023, the University of Nottingham secured £1.1 million in funding from the Medical Research Council to conduct human trials for the world’s first optical fibre sensor-equipped endotracheal tube, known as iTraXS.

• In June 2023, Teleflex Incorporated, a global provider of medical technologies for critical care and surgery, announced a global recall of certain batches of Rüsch Endotracheal Tube products. These devices are designed for oral or nasal intubation to manage the airway by inserting the tube into a patient’s trachea through the nose or mouth, with stylets used to assist in proper placement.

• In June 2023, SunMed was selected to showcase the SolidAIRity Flex Oral Endotracheal Tube Stabilization Device at the Vizient Innovative Technology Exchange. The event, organized by Vizient, Inc., the nation’s largest member-driven healthcare performance improvement company, is scheduled for October 3 in Grapevine, Texas. 

Endotracheal Tube Market Report Scope

Global Endotracheal Tube Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global endotracheal tube market report based on product, route, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Regular Endotracheal Tube

  • Reinforced Endotracheal Tube

  • Preformed Endotracheal Tube

  • Double lumen Endotracheal Tube

• Route Outlook (Revenue, USD Million, 2021 - 2033)

  • Orotracheal

  • Nasotracheal

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Emergency Treatment

  • Therapy

  • Others

• End Use Outlook (Revenue, USD Million; 2021 - 2033)

  • Hospitals and Clinics

  • Ambulatory Surgical Centers

  • Emergency Care Facilities/Urgent Care

  • Others (Long-Term Facilities, Physician Offices, Nursing Homes)

  • EMS (Fire/Rescue/Ambulance/Hospital Based EMS)

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait